Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AGORA Investor Relations (AGORACOM) is a prominent digital investor relations and corporate communications firm that specializes in the small-cap and micro-cap public markets. Founded in 1997 and headquartered in Toronto, Canada, the firm is a pioneer in online investor engagement, notably through its "AGORACOM IR HUB" platform, which provides moderated discussion forums for public companies and their investors. AGORACOM has a significant presence in the life sciences and biotechnology sectors, having provided IR and marketing services to numerous emerging healthcare companies to help them navigate the complexities of the public markets. While the firm is a service provider rather than a drug developer, it is a well-recognized name in the biotech ecosystem for its role in facilitating transparent communication between issuers and the investment community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AGORA Investor Relations.